Optas LLC’s Eastman Chemical EMN Stock Holding History

Optas LLC’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,056	Closed	-$228K	–	407
2025 Q2	$228K	Buy	+3,056	New	+$240K	0.04%	290

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Optas LLC's EMN Position: Q3 2025 in Review

Optas LLC sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 3,056 shares — an estimated $228K sold.

Optas LLC first reported a position in EMN in Q2 2025 and held it in 1 quarter. The position peaked at $228K in Q2 2025. 663 funds tracked by Wall St. Rank hold EMN as of Q3 2025.

Optas LLC reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
Optas LLC sold 3,056 Eastman Chemical shares in Q3 2025, an estimated $228K.
Optas LLC first reported a position in Eastman Chemical in Q2 2025 and held it in 1 quarter.
Optas LLC's Eastman Chemical position peaked at $228K in Q2 2025.
663 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.

Based on Optas LLC's 13F filing for Q3 2025, filed 15 Oct 2025.